{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:55Z","timestamp":1787071075701,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a highly aggressive hematologic neoplasm and classified under acute myeloid leukemia. Here, we describe the clinicopathological features of three cases of BPDCN: two with classical and one uncommon immunophenotype. A-35-year-old female (case 1) presented with complaint of nasal mass and generalized lymphadenopathy. Biopsy from axillary lymph node showed infiltration by cells with scant cytoplasm which were immunopositive for LCA, CD4, CD43, and ALK1. Flowcytometry showed positivity for CD45, CD4, CD33, and CD123 while negative for rest all markers. The other two cases have classical immunophenotype. In clinical practice, nasal mass with lymphadenopathy suggests natural killer T-cell\/peripheral T-cell lymphoma. Again immunohistochemical positivity for CD4, CD43, and ALK while negativity for CD3 suggests anaplastic large cell lymphoma. In this case, morphology and extensive bone marrow involvement raise the suspicion. Fowcytometry positivity for HLADR, CD123, and CD33 helps in making diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_420_20","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T07:32:56Z","timestamp":1629444776000},"page":"S471-S474","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Blastic plasmacytoid dendritic cell neoplasm"],"prefix":"10.4103","volume":"18","author":[{"given":"Suvendu","family":"Purkait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumyaranjan","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-54-20241021","first-page":"58","article-title":"Incidence and characteristics of CD4(+)\/HLA DRhi dendritic cell malignancies","volume":"89","author":"Bueno","year":"2004","journal-title":"Haematologica"},{"key":"R3-54-20241021","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"R4-54-20241021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.leukres.2018.08.014","article-title":"Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm","volume":"73","author":"Guru Murthy","year":"2018","journal-title":"Leuk Res"},{"key":"R5-54-20241021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jdermsci.2020.01.010","article-title":"Cutaneous lymphoma in Japan, 2012-2017: A nationwide study","volume":"97","author":"Fujii","year":"2020","journal-title":"J Dermatol Sci"},{"key":"R6-54-20241021","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.18632\/oncotarget.4146","article-title":"Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile","volume":"6","author":"Mart\u00edn-Mart\u00edn","year":"2015","journal-title":"Oncotarget"},{"key":"R7-54-20241021","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/DAD.0000000000000348","article-title":"Blastic plasmacytoid dendritic cell neoplasm in the pediatric population: A case series and review of the literature","volume":"37","author":"Nguyen","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R8-54-20241021","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","article-title":"Blastic plasmacytoid dendritic cell neoplasms: Clinico-immunohistochemical correlations in a series of 91 patients","volume":"38","author":"Julia","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R9-54-20241021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0b013e3181c5e26b","article-title":"Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients","volume":"34","author":"Cota","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R10-54-20241021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2133.2004.06296.x","article-title":"CD56-negative blastic natural killer-cell lymphoma (agranular CD4(+)\/CD56(+) haematodermic neoplasm)?","volume":"152","author":"Kawai","year":"2005","journal-title":"Br J Dermatol"},{"key":"R11-54-20241021","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2012-08-447599","article-title":"SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: Characterization of its expression in major hematolymphoid neoplasms","volume":"121","author":"Montes-Moreno","year":"2013","journal-title":"Blood"},{"key":"R12-54-20241021","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2004-06-2416","article-title":"Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells","volume":"105","author":"Garnache-Ottou","year":"2005","journal-title":"Blood"},{"key":"R13-54-20241021","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","article-title":"Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia","volume":"145","author":"Garnache-Ottou","year":"2009","journal-title":"Br J Haematol"},{"key":"R14-54-20241021","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","article-title":"Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm","volume":"43","author":"Sukswai","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R15-54-20241021","doi-asserted-by":"crossref","first-page":"e230332","DOI":"10.1136\/bcr-2019-230332","article-title":"Blastic plasmacytoid dendritic cell neoplasm in the background of myeloproliferative disorder and chronic lymphocytic leukaemia","volume":"12","author":"Khan","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R16-54-20241021","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3324\/haematol.2018.202093","article-title":"Blastic plasmacytoid dendritic cell neoplasm: Genomics mark epigenetic dysregulation as a primary therapeutic target","volume":"104","author":"Sapienza","year":"2019","journal-title":"Haematologica"},{"key":"R17-54-20241021","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/gcc.22119","article-title":"CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm","volume":"53","author":"Tokuda","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"R18-54-20241021","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N Engl J Med"},{"key":"R19-54-20241021","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood.2019001144","article-title":"Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark","volume":"134","author":"Taylor","year":"2019","journal-title":"Blood"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_420_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:06Z","timestamp":1787067666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_420_20"}},"subtitle":["A clinicopathological diagnostic dilemma report of three cases with review of literature"],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":18,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_420_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}